Please join Ocular Therapeutix™ for its 2026 Investor Day featuring prominent retinal disease Key Opinion Leaders (KOLs) and presentations from senior Company leadership.

A live question and answer session will follow the formal presentations. Additional event information and logistics will be provided in advance.